Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2025 | Story Lacea Loader

Academic activities at the University of the Free State (UFS) will continue on Monday 20 October 2025.

The Executive Committee of the university appreciates the understanding and cooperation of all staff and students during this time. 

The academic calendar has been amended to ensure the successful completion of the 2025 academic year. 

 

1. Academic calendar

The end of the fourth quarter will be postponed, and the start of the main end-of-year examinations will be moved from 3 November to 10 November 2025.

This decision applies to all students, except final-year students in the Faculty of Health Sciences.

Final-year students in the Faculty of Health Sciences will commence their year-end examinations on 3 November 2025 to enable them to graduate in December 2025 and begin their community service/internships in January 2026.

Information to support the continuation and completion of lectures and assessments will be communicated by the respective lecturers.

Our students are encouraged to consult their lecturers or programme coordinators with any queries.

 

2. Qwaqwa Campus

The Qwaqwa Campus will reopen on Monday 20 October 2025, with staff and students returning as follows:

  • Monday 20 October 2025: University Estates staff
  • Tuesday 21 October 2025: Academic staff and professional and support services staff
  • Wednesday 22 October 2025: Residence students
  • Thursday 23 October 2025: Resumption of all academic activities

The university extends its appreciation to staff and students for their patience, commitment, and resilience.

 

Issued by:
Lacea Loader 
Senior Director: Communication and Marketing
University of the Free State 

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept